SELECTIVE PROGESTERONE MODULATORS IN THE TREATMENT OF UTERINE BLEEDING

Progesterone antagonists and SPRM are useful to prepare a medication for the treatment or the prophylaxis of excessive uterine bleeding in women with spontaneous or iatrogenic coagulation disorders such as thrombopenia, coagulation factor deficiency or anti-coagulant therapy. Treatment will last fro...

Full description

Saved in:
Bibliographic Details
Main Authors FAUSER, BARTHOLOMEUS, C., J., M, LOUMAYE, ERNEST
Format Patent
LanguageEnglish
French
German
Published 03.02.2010
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Progesterone antagonists and SPRM are useful to prepare a medication for the treatment or the prophylaxis of excessive uterine bleeding in women with spontaneous or iatrogenic coagulation disorders such as thrombopenia, coagulation factor deficiency or anti-coagulant therapy. Treatment will last from 1 day to 180 days.
Bibliography:Application Number: EP20080737471